Add-on salmeterol compared to double dose fluticasone in pediatric asthma: A double-blind, randomized trial (VIAPAED)

Pediatric Pulmonology

Volumn 44, Issue 11, 2009, Pages 1132-1142

  Gappa, Monika ^a,c   Zachgo, Wolfgang ^b   Von Berg, Andrea ^c   Kamin, Wolfgang ^d   Stern Sträter, Catrin ^e   Steinkamp, Gratiana ^f  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Marien Hospital Wesel Ggmbh ^*

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d Glaxo Smith Kline   (Germany)

^e Clinical Research   (Germany)

^f MARIEN HOSPITAL WESEL   (Germany)

Author keywords

Asthma; Asthma control; Child; Comparison; Efficacy; Fluticasone; Inhaled corticosteroid; Long acting beta 2 agonist; Salmeterol

Indexed keywords

FLUTICASONE PROPIONATE; SALMETEROL;

ADD ON THERAPY; ADOLESCENT; ARTICLE; ASTHMA; BRONCHITIS; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE CONTROL; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INHALER; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; RHINITIS; RHINOPHARYNGITIS; SCHOOL CHILD; SINUSITIS; SPIROMETRY; TONSILLITIS; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VOMITING;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANDROSTADIENES; ASTHMA; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PEAK EXPIRATORY FLOW RATE;

EID: 72449152221     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21120     Document Type: Article

References (21)

1. Anderson HR, Gupta R, Strachan DP, Limb ES. 50 years of asthma: UK trends from 1955 to 2004. Thorax 2007;62:85-90.
2. Lau S, Nickel R, Niggemann B, Gruber C, Sommerfeld C, Illi S, et al. The development of childhood asthma: lessons from the German Multicentre Allergy Study (MAS). Paediatr Respir Rev 2002;3:265-272. (Pubitemid 35314889)
3. Barnes PJ. Molecular mechanisms of antiasthma therapy. Ann Med 1995;27:531-535.
4. Guevara JP, Ducharme FM, Keren R, Nihtianova S, Zorc J. Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma. Cochrane Database Syst Rev 2006, Apr 19;(2):CD 003558.
5. Global initiative for asthma (GINA). Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2006. National Institutes of Health; 2007.
6. Verberne AA, Frost C, Roorda RJ, van der Laag H, Kerrebijn KF. One-year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group [see comments]. Am J Respir Crit Care Med 1997;156:688-695.
7. Verberne AA, Frost C, Duiverman EJ, Grol MH, Kerrebijn KF. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. Am J Respir Crit Care Med 1998;158:213-219.
8. Bergmann KC, Lindemann L, Braun R, Steinkamp G. Salmeterol/ fluticasone propionate (50/250 microg) combination is superior to double dose fluticasone (500 microg) for the treatment of symptomatic moderate asthma. Swiss Med Wkly 2004;134:50-58. (Pubitemid 38139882)
9. Shapiro G, Lumry W, Wolfe J, Given J, White MV, Woodring A, et al. Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma. Am J Respir Crit Care Med 2000;161:527-534. (Pubitemid 30129463)
10. Wolthers OD. Impact of inhaled and intranasal corticosteroids on the growth of children. BioDrugs 2000;13:347-357. (Pubitemid 30399447)
11. O'Connor RD, Rosenzweig JR, Stanford RH, Gilmore AS, Ryskina KL, Legorreta AP, et al. Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens. Ann Allergy Asthma Immunol 2005;95:535-540.
12. Marceau C, Lemiere C, Berbiche D, Perreault S, Blais L. Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J Allergy Clin Immunol 2006; 118:574-581. (Pubitemid 44301411)
13. de Blic J, Ogorodova L, Klink R, Sidorenko I, Valiulis A, Hofman J, et al. Salmeterol/fluticasone propionate versus double dose fluticasone propionate in children. Pediatr Allergy Immunol 2009; Epub 22 Feb 2009.
14. Bracamonte T, Schauer U, Emeryk A, Godwood A, Balsara S. Salmeterol/fluticasone propionate combination delivered by the diskus or pressurised metered-dose inhaler in children with asthma. Clin Drug Invest 2005;25:1-11. (Pubitemid 40070108)
15. Malone R, LaForce C, Nimmagadda S, Schoaf L, House K, Ellsworth A, et al. The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma. Ann Allergy Asthma Immunol 2005;95:66-71. (Pubitemid 41022775)
16. Van Den Berg NJ, Ossip MS, Hederos CA, Anttila H, Ribeiro BL, Davies PI. Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma. Pediatr Pulmonol 2000;30:97-105.
17. Sorkness CA, Lemanske RF Jr, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, et al. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 2007;119:64-72.
18. Jones C, Santanello NC, Boccuzzi SJ, Wogen J, Strub P, Nelsen LM. Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data. J Asthma 2003;40:93-101. (Pubitemid 36417352)
19. Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza R Jr. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol 2004;113:245-251. (Pubitemid 38210545)
20. Bengoa R. Adherence to long-term therapies: evidence for action. WHO/MNC/03.01. World Health Organization; 2003.
21. Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting ß2-Agonists and corticosteroids. Eur Respir J 2002;19:182-191.